Re: Defining the potential of neoadjuvant chemotherapy use as a quality indicator for bladder cancer care: G. Vemana, K. G. Nepple, J. Vetter, G. Sandhu and S. A. Strope J Urol 2014; 192: 43-49

J Urol. 2015 Jan;193(1):370-1. doi: 10.1016/j.juro.2014.07.119. Epub 2014 Oct 7.

Authors

S S Goonewardene¹, A Bahl², R Persad²

Affiliations

¹ Guys Hospital, Kings College, London, United Kingdom.
² Southmead Hospital, Bristol, United Kingdom.

PMID: 25300161
DOI: 10.1016/j.juro.2014.07.119

No abstract available

Publication types

Letter
Comment

MeSH terms

Female
Humans
Male
Quality Indicators, Health Care*
Urinary Bladder Neoplasms / drug therapy*